PatentVerwendung von Substanzen, die den zellulären Glutathion-Gehalt absenken, zur Herstellung eines Arzneimittels zur…
Basic data
Title:
Verwendung von Substanzen, die den zellulären Glutathion-Gehalt absenken, zur Herstellung eines Arzneimittels zur Behandlung von T-Zell vermittelten Autoimmunkrankheiten
Reference number (DPMA):
10 2006 058 183
Primary registration:
29/11/2006
Inventors
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
CRC-TR 156 - The Skin as a Sensor and Effector Organ Orchestrating Local and Systemic Immune Responses
Collaborative research centers and transregios
Collaborative research centers and transregios
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Weigert, Christina Mathilde
formerly Universität Tübingen
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
National patents
PCT Registration
Registration date:
31/10/2007
Registration number:
PCT/EP2007/009433
Nationalizations
Patent familiy:
10 2006 058 183, US12/474,184, EP20070819467, EP20110008821
US12/474,184
USA: United States Patent and Trademark Office
28/05/2009
31/12/2013
EP20070819467
European Patent Office
31/10/2007
25/05/2016
EP20110008821
European Patent Office
31/10/2007
30/11/2016